F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000
The Food and Drug Administration approved the first treatment that genetically alters a patient ’ s own cells to fight cancer. It will cost $475,000.
Source: NYT Health - Category: Consumer Health News Authors: DENISE GRADY Tags: Leukemia Immune System Genetic Engineering Cancer Children's Hospital of Philadelphia Food and Drug Administration Novartis AG University of Pennsylvania June, Carl H Whitehead, Emma Source Type: news
More News: Cancer | Cancer & Oncology | Children | Food and Drug Administration (FDA) | Genetics | Health | Hospitals | Leukemia | University of Pennsylvania